SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "(WFRF:(Hillege Hans L.)) srt2:(2015-2019) srt2:(2015)"

Sökning: (WFRF:(Hillege Hans L.)) srt2:(2015-2019) > (2015)

  • Resultat 1-2 av 2
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Shungin, Dmitry, et al. (författare)
  • New genetic loci link adipose and insulin biology to body fat distribution.
  • 2015
  • Ingår i: Nature. - : Springer Science and Business Media LLC. - 0028-0836 .- 1476-4687. ; 518:7538, s. 187-378
  • Tidskriftsartikel (refereegranskat)abstract
    • Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links to cardiometabolic traits, here we conduct genome-wide association meta-analyses of traits related to waist and hip circumferences in up to 224,459 individuals. We identify 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (BMI), and an additional 19 loci newly associated with related waist and hip circumference measures (P < 5 × 10(-8)). In total, 20 of the 49 waist-to-hip ratio adjusted for BMI loci show significant sexual dimorphism, 19 of which display a stronger effect in women. The identified loci were enriched for genes expressed in adipose tissue and for putative regulatory elements in adipocytes. Pathway analyses implicated adipogenesis, angiogenesis, transcriptional regulation and insulin resistance as processes affecting fat distribution, providing insight into potential pathophysiological mechanisms.
  •  
2.
  • Meijers, Wouter C., et al. (författare)
  • Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH
  • 2015
  • Ingår i: European Journal of Heart Failure. - : WILEY-BLACKWELL. - 1388-9842 .- 1879-0844. ; 17:12, s. 1271-1282
  • Tidskriftsartikel (refereegranskat)abstract
    • AimTraditionally, risk stratification in heart failure (HF) emphasizes assessment of high risk. We aimed to determine if biomarkers could identify patients with HF at low risk for death or HF rehospitalization. Methods and resultsThis analysis was a substudy of The Coordinating Study Evaluating Outcomes of Advising and Counselling in Heart Failure (COACH) trial. Enrolment of HF patients occurred before discharge. We defined low risk as the absence of death and/or HF rehospitalizations at 180days. We tested a diverse group of 29 biomarkers on top of a clinical risk model, with and without N-terminal pro-B-type natriuretic peptide (NT-proBNP), and defined the low risk biomarker cut-off at the 10th percentile associated with high positive predictive value. The best performing biomarkers together with NT-proBNP and cardiac troponin I (cTnI) were re-evaluated in a validation cohort of 285 HF patients. Of 592 eligible COACH patients, the mean (SD) age was 71 (+/- 11) years and median (IQR) NT-proBNP was 2521 (1301-5634) pg/mL. Logistic regression analysis showed that only galectin-3, fully adjusted, was significantly associated with the absence of events at 180days (OR 8.1, 95% confidence interval 1.06-50.0, P=0.039). Galectin-3, showed incremental value when added to the clinical risk model without NT-proBNP (increase in area under the curve from 0.712 to 0.745, P=0.04). However, no biomarker showed significant improvement by net reclassification improvement on top of the clinical risk model, with or without NT-proBNP. We confirmed our results regarding galectin-3, NT-proBNP, and cTnI in the independent validation cohort. Conclusion We describe the value of various biomarkers to define low risk, and demonstrate that galectin-3 identifies HF patients at (very) low risk for 30-day and 180-day mortality and HF rehospitalizations after an episode of acute HF. Such patients might be safely discharged.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-2 av 2
Typ av publikation
tidskriftsartikel (2)
Typ av innehåll
refereegranskat (2)
Författare/redaktör
Jaarsma, Tiny (1)
Berne, Christian (1)
Lyssenko, Valeriya (1)
Groop, Leif (1)
Lorentzon, Mattias, ... (1)
März, Winfried (1)
visa fler...
Salomaa, Veikko (1)
Perola, Markus (1)
Chen, Jin (1)
Lind, Lars (1)
Raitakari, Olli T (1)
Kuh, Diana (1)
Haiman, Christopher ... (1)
Berndt, Sonja I (1)
de Boer, Rudolf A. (1)
Campbell, Harry (1)
Rudan, Igor (1)
Staessen, Jan A (1)
Ohlsson, Claes, 1965 (1)
Voors, Adriaan A. (1)
Strachan, David P (1)
Deloukas, Panos (1)
Syvänen, Ann-Christi ... (1)
Peters, Ulrike (1)
Johansson, Ingegerd (1)
Shungin, Dmitry (1)
North, Kari E. (1)
Franks, Paul W. (1)
Wareham, Nicholas J. (1)
Hallmans, Göran (1)
Clarke, Robert (1)
Fall, Tove (1)
Stancáková, Alena (1)
Kuusisto, Johanna (1)
Laakso, Markku (1)
McCarthy, Mark I (1)
Ferrannini, Ele (1)
Franco-Cereceda, And ... (1)
Olsson, Christian (1)
Sandholm, Niina (1)
Sennblad, Bengt (1)
Eriksson, Per (1)
Renström, Frida (1)
Ridker, Paul M. (1)
Chasman, Daniel I. (1)
Demirkan, Ayse (1)
Amin, Najaf (1)
van Duijn, Cornelia ... (1)
Rose, Lynda M (1)
Langenberg, Claudia (1)
visa färre...
Lärosäte
Göteborgs universitet (1)
Umeå universitet (1)
Uppsala universitet (1)
Linköpings universitet (1)
Lunds universitet (1)
Karolinska Institutet (1)
visa fler...
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (1)
Samhällsvetenskap (1)
År
2015 (2)Ta bort avgränsningen

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy